Bretylium Tosylate CAS: 61-75-6
MF: C18H24BrNO3S
MW: 414.36
An inhibitor of AChE.

Bretylium Tosylate (CAS 61-75-6)

Bretylium Tosylate | CAS 61-75-6 is rated 5.0 out of 5 by 1.
  • y_2021, m_1, d_15, h_16
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.12
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_360745, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 133ms
  • REVIEWS, PRODUCT
5
1
4
0
3
0
2
0
1
0
Alternate Names: Bretylol; Bretylate; Ornid
Application: Bretylium Tosylate is an inhibitor of AChE
CAS Number: 61-75-6
Molecular Weight: 414.36
Molecular Formula: C18H24BrNO3S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).

Bretylium Tosylate is an inhibitor of AChE. Bretylium tosylate has a biphasic response, initially inducing norepinephrine release followed by sympathetic ganglionic blockade. Bretylium tosylate is a class III antiarrhythmic agent and a competitive inhibitor of acetylcholinesterase

Appearance :
Powder
Physical State :
Solid
Solubility :
Soluble in water (50 mg/ml), ethanol, methanol, and chloroform. Insoluble in ether, ethyl acetate, and hexane.
Storage :
Store at room temperature
Melting Point :
97.8° C
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
WGK Germany :
3
RTECS :
BO9450000
PubChem CID :
6100
Merck Index :
14: 1371
MDL Number :
MFCD00038731
EC Number :
200-516-8
SMILES :
CC[N+](C)(C)CC1=CC=CC=C1Br.CC1=CC=C(C=C1)S(=O)(=O)[O-]

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 98ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from McGinn et al McGinn et al. (PubMed ID 24687586) found that Bretylium Tosylate inhibited noradrenergic vasoconstriction and increased postexercise cutaneous vascular conductance. -SCBT Publication Review
Date published: 2015-05-14
  • y_2021, m_1, d_15, h_16
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.12
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_360745, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 7ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.